Pimblett Emily's Form 4 filing
Climb Bio, Inc. (CLYM) · filed Dec 20, 2024
- Accession no.
- 0000950170-24-139052
- Filed
- Dec 20, 2024
- Trade date
- Dec 18-19, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.49K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pimblett EmilyCIK 0001969365 | Officer (CHIEF ACCOUNTING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | Common Stock | MOption exerciseAcquired | +5,000 | – | – | 12,564 | Direct | |
| Dec 19, 2024 | Common Stock | SSaleDisposed | −1,235 | $2.02 | −$2,494.7 | 11,329 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 25,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.